Global Blood Therapeutics
Why Robinhood?
You can watch GBT and buy or sell other stocks, ETFs, and their options commission-free!About GBT
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases.
GBT Key Statistics
Stock Snapshot
Global Blood Therapeutics(GBT) stock is priced at $68.49, giving the company a market capitalization of 4.62B. It carries a P/E multiple of -13.70.
On 2026-03-14, Global Blood Therapeutics(GBT) stock opened at —, reached a high of —, and a low of —.
The Global Blood Therapeutics(GBT)'s current trading volume is 0, compared to an average daily volume of 2.06M.
In the last year, Global Blood Therapeutics(GBT) shares hit a 52-week high of $73.02 and a 52-week low of $21.65.
In the last year, Global Blood Therapeutics(GBT) shares hit a 52-week high of $73.02 and a 52-week low of $21.65.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.